CHC Healthcare Group

As of June 30, 2026, CHC Healthcare Group carries a market capitalization of 5.59B, placing it among publicly traded companies globally. Its enterprise value stands at 10.25B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

CHC Healthcare Group's next confirmed earnings release is scheduled for November 11, 2026.

As of June 30, 2026, CHC Healthcare Group has 193.81M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, CHC Healthcare Group maintains a current ratio of 1.70, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, CHC Healthcare Group recorded 70.88M in income tax expense.

As of the close on October 22, 2026, CHC Healthcare Group's stock has declined approximately 39.66% over the past 52 weeks. The 50-day moving average sits at 26.63, while the 200-day moving average is 29.88.

As of June 30, 2026, CHC Healthcare Group holds 1.53B in cash and equivalents against 5.79B in total debt, resulting in a net debt position of 4.00B. Total book value stands at 7.47B, with working capital of 2.15B providing operational flexibility.

CHC Healthcare Group produced 445.41M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -602.84M in capital expenditures, free cash flow totaled -157.43M - equivalent to -0.81 per share.

Over the twelve months ended June 30, 2026, CHC Healthcare Group paid dividends of - - per share. Free cash flow yield is negative at -2.73: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow.

CHC Healthcare Group's most recent stock split took place on December 1, 2015 with a 787:791 split ratio.